Novavax
NVAX
#5737
Rank
A$1.90 B
Marketcap
A$11.57
Share price
-3.02%
Change (1 day)
14.65%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -A$0.34 Billion

According to Novavax's latest financial reports the company's current earnings are A$0.41 Billion. In 2025 the company made an earning of A$0.69 Billion, an increase over its 2024 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.34 Billion-148.11%
2025 A$0.69 B-396.87%
2024 -A$0.24 Billion-70.39%
2023 -A$0.8 Billion-16.59%
2022 -A$0.96 Billion-62.58%
2021 -A$2.54 Billion320.54%
2020 -A$0.61 Billion234.22%
2019 -A$0.19 Billion-30.17%
2018 -A$0.26 Billion1.69%
2017 -A$0.26 Billion-36.44%
2016 -A$0.41 Billion70.4%
2015 -A$0.24 Billion89.27%
2014 -A$0.13 Billion59.83%
2013 -A$77.65 Million81.9%
2012 -A$42.69 Million50.33%
2011 -A$28.4 Million
2009 -A$56.04 Million8.8%
2008 -A$51.51 Million18.01%
2007 -A$43.65 Million18.33%
2006 -A$36.89 Million168.31%
2005 -A$13.75 Million-62.51%
2004 -A$36.68 Million52.4%
2003 -A$24.07 Million-28.21%
2002 -A$33.52 Million
2000 -A$19.11 Million177%
1999 -A$6.9 Million-11.54%
1998 -A$7.8 Million10.64%
1997 -A$7.05 Million-9.62%
1996 -A$7.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$18.95 B-5,758.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$10.44 B-3,218.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$22.61 B-6,853.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$10.72 B-3,302.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$0.2 Billion-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.49 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.22 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$12.32 Million-96.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$0.54 Billion 58.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.3 Billion-12.90%๐Ÿ‡บ๐Ÿ‡ธ USA